DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
FRA:DRW8 - Deutsche Boerse Ag - DE0005550602 - Common Stock - Currency: EUR
Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 55 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of DRW8 get a neutral evaluation. Nothing too spectacular is happening here. DRW8 is valued quite cheap, while showing a decent growth score. This is a good combination! This makes DRW8 very considerable for value investing!
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
In the past year DRW8 had a positive cash flow from operations.
Of the past 5 years DRW8 4 years were profitable.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
1.2 Ratios
DRW8 has a Return On Assets of 3.75%. This is in the better half of the industry: DRW8 outperforms 63.64% of its industry peers.
With a decent Return On Equity value of 7.54%, DRW8 is doing good in the industry, outperforming 63.64% of the companies in the same industry.
DRW8 has a better Return On Invested Capital (7.13%) than 67.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROIC | 7.13% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8 has a Profit Margin (3.42%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
DRW8 has a Operating Margin (5.77%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
The Gross Margin of DRW8 (44.97%) is worse than 61.82% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
The number of shares outstanding for DRW8 has been reduced compared to 1 year ago.
DRW8 has more shares outstanding than it did 5 years ago.
DRW8 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.60 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DRW8 (2.60) is comparable to the rest of the industry.
DRW8 has a debt to FCF ratio of 2.08. This is a good value and a sign of high solvency as DRW8 would need 2.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.08, DRW8 belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
The Debt to Equity ratio of DRW8 (0.10) is better than 83.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Altman-Z | 2.6 |
ROIC/WACC1.14
WACC6.26%
2.3 Liquidity
A Current Ratio of 1.81 indicates that DRW8 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.81, DRW8 perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
DRW8 has a Quick Ratio of 1.12. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8 has a Quick ratio (1.12) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.79% over the past year.
Measured over the past years, DRW8 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 0.51%.
DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
3.2 Future
Based on estimates for the next years, DRW8 will show a small growth in Earnings Per Share. The EPS will grow by 6.55% on average per year.
The Revenue is expected to grow by 2.64% on average over the next years.
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.33, which indicates a very decent valuation of DRW8.
Based on the Price/Earnings ratio, DRW8 is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.46. DRW8 is valued rather cheaply when compared to this.
DRW8 is valuated reasonably with a Price/Forward Earnings ratio of 8.25.
98.18% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DRW8 to the average of the S&P500 Index (36.44), we can say DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.33 | ||
| Fwd PE | 8.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 96.36% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.33 | ||
| EV/EBITDA | 2.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)11.39
PEG (5Y)0.26
EPS Next 2Y8.16%
EPS Next 3Y10.79%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.41%, DRW8 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.07, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 94.55% of the companies listed in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
5.2 History
The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
DRW8 pays out 28.77% of its income as dividend. This is a sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.77%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
FRA:DRW8 (7/22/2025, 5:10:34 PM)
57.4
-0.4 (-0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.08B
Analysts74.67
Price Target72.65 (26.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP28.77%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.22%
PT rev (3m)12.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.33 | ||
| Fwd PE | 8.25 | ||
| P/S | 0.32 | ||
| P/FCF | 8.33 | ||
| P/OCF | 5.68 | ||
| P/B | 0.7 | ||
| P/tB | 0.91 | ||
| EV/EBITDA | 2.99 |
EPS(TTM)6.15
EY10.71%
EPS(NY)6.95
Fwd EY12.12%
FCF(TTM)6.89
FCFY12.01%
OCF(TTM)10.11
OCFY17.62%
SpS179.39
BVpS81.51
TBVpS63.3
PEG (NY)11.39
PEG (5Y)0.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROCE | 9.48% | ||
| ROIC | 7.13% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 10.31% | ||
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% | ||
| FCFM | 3.84% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Debt/EBITDA | 0.45 | ||
| Cap/Depr | 41.06% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 10.18 | ||
| Cash Conversion | 55.59% | ||
| Profit Quality | 112.21% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 2.6 |
F-Score6
WACC6.26%
ROIC/WACC1.14
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
EBIT growth 1Y16.32%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.53%
EBIT Next 3Y29.41%
EBIT Next 5Y12.44%
FCF growth 1Y165.3%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y253.6%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%